# OnCo record isg-sts-1001 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/isg-sts-1001/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "isg-sts-1001", "NCT01710176" ;
  schema:name "ISG-STS 1001"@en ;
  schema:description "Standard anthracycline-ifosfamide before surgery beat subtype-tailored chemotherapy, and indirectly showed neoadjuvant chemotherapy helps high-risk sarcoma."@en ;
  schema:url <https://onco.cc/trials/isg-sts-1001/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01710176> ;
  onco:status "positive" ;
  onco:phase "3" ;
  schema:startDate "2011-06-01" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/>, <https://onco.cc/cancers/extremity-soft-tissue-sarcoma/>, <https://onco.cc/cancers/undifferentiated-pleomorphic-sarcoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:drugs <https://onco.cc/drugs/ifosfamide/> ;
  onco:companies <https://onco.cc/companies/italian-sarcoma-group/> ;
  onco:terms <https://onco.cc/terms/fnclcc-grade/>, <https://onco.cc/terms/sarcoma-histotype-tailoring/> ;
  onco:people <https://onco.cc/people/alessandro-gronchi/> .